Differential effects of 5-HT2C receptor ligands on place conditioning and locomotor activity in rats

European Journal of Pharmacology

Volumn 515, Issue 1-3, 2005, Pages 107-116

  Mosher, Tera ^a   Hayes, David ^a   Greenshaw, Andrew ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

(Rat); 5 HT2C receptor; Locomotor activity; Place conditioning

Indexed keywords

1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; 8,9 DICHLORO 2,3,4,4A TETRAHYDRO 1H PYRAZINO[1,2 A]QUINOXALIN 5(6H) ONE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; SEROTONIN 1A AGONIST; SEROTONIN 1B AGONIST; SEROTONIN 2C AGONIST; SEROTONIN 2C RECEPTOR; UNCLASSIFIED DRUG; WAY 161503;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; LOCOMOTION; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REINFORCEMENT;

AMINOPYRIDINES; ANIMALS; CONDITIONING (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; INDOLES; LIGANDS; MALE; MOTOR ACTIVITY; OXADIAZOLES; PIPERAZINES; PYRAZINES; PYRIDINES; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTOR, SEROTONIN, 5-HT2C; SEROTONIN ANTAGONISTS; TIME FACTORS;

EID: 20344392672     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.03.041     Document Type: Article

References (63)

1. K.C. Ahn, H. Pazderka-Robinson, R. Clements, R. Ashcroft, T. Ali, C. Morse, and A.J. Greenshaw Differential effects of intra-midbrain raphe and systemic 8-OH-DPAT on VTA self-stimulation thresholds in rats Psychopharmacology (Berl) 2004
2. E.C. Azmitia, and M. Segal An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat J. Comp. Neurol. 179 1978 641 668
3. N.M. Barnes, and T. Sharp A review of central 5-HT receptors and their function Neuropharmacology 38 1999 1083 1152
4. E. Bilsky, and J. Reid MDL72222, a serotonin 5-HT3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preference Pharmacol. Biochem. Behav. 39 1991 509 512
5. F.G. Boess, and I.L. Martin Molecular biology of 5-HT receptors Neuropharmacology 33 1994 275 317
6. J.J. Burmeister, E.M. Lungren, K.F. Kirschner, and J.L. Neisewander Differential roles of 5-HT receptor subtypes in cue and cocaine reinstatement of cocaine-seeking behavior in rats Neuropsychopharmacology 29 2004 660 668
7. 1B receptors induces conditioned place aversion and facilitates cocaine place conditioning in rats Psychopharmacology 163 2002 142 150
8. 2C receptor-related changes in VTA electrical self-stimulation thresholds in rats.
9. J.F. Cryan, and I. Lucki Antidepressant-like behavioural effects mediated by 5-hydroxytryptamine2C receptors J. Pharmacol. Exp. Ther. 295 2000 1120 1126
10. G. Di Giovanni, V. Di Matteo, M. Di Mascio, and E. Esposito Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin2C/2B receptor agonists: a combined in vivo electrophysiological and microdialysis study Synapse 35 2000 53 61
11. G. Di Giovanni, V. Di Matteo, V. La Grutta, and E. Esposito m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors Neuroscience 103 2001 111 116
12. 2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system Neuropharmacology 38 1999 1195 1205
13. 2C receptor antagonist CNS Drug Rev. 6 2000 195 205
14. 2C receptors Brain Res. 865 2000 85 90
15. 2C receptors in the control of central dopamine function Trends Pharmacol. Sci. 22 2001 29 32
16. 2C receptors in the control of brain dopaminergic function Pharmacol. Biochem. Behav. 71 2002 727 734
17. S.B. Dunnett, and T.W. Robbins The functional role of mesotelencephalic dopamine systems Biol. Rev. Camb. Philos. Soc. 67 1992 491 518
18. 2C receptor messenger RNA in the basal ganglia of adult rats J. Comp. Neurol. 384 1997 233 247
19. 2C receptors in nucleus accumbens regulate expression of the hyperlocomotive and discriminative stimulus effects of cocaine Pharmacol. Biochem. Behav. 71 2002 45 56
20. P.J. Fletcher, Z.H. Ming, and G.A. Higgins Conditioned place preference induced by microinjection of 8-OH-DPAT into the dorsal or median raphe nucleus Psychopharmacology 113 1993 31 36
21. P.J. Fletcher, M. Tampakeras, and J.S. Yeomans Median raphe injections of 8-OH-DPAT lower frequency thresholds for lateral hypothalamic self-stimulation Pharmacol. Biochem. Behav. 52 1995 65 71
22. 1B receptors in the nucleus accumbens reduces self-administration of amphetamine on a progressive ratio schedule Pharmacol. Biochem. Behav. 71 2002 717 725
23. 2C receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding Neurospsychopharmacology 27 2002 578 586
24. 2C receptor agonist Ro60-0175 into the ventral tegmental area reduces cocaine-induced locomotor activity and cocaine self-administration Neuropsychopharmacology 29 2004 308 318
25. Y.K. Fung, and Y.S. Lau Receptor mechanisms of nicotine-induced locomotor hyperactivity in chronic nicotine treated rats Eur. J. Pharamacol. 2 1988 263 271
26. 2A, or 5-HT2B receptors Behav. Pharmacol. 12 2001 613 620
27. 2C receptors on cocaine- and food-maintained behavior J. Pharm. Exp. Ther. 295 2000 1183 1191
28. 2C receptors reduces the locomotor and rewarding effects of nicotine Psychopharmacology 157 2001 292 298
29. A.A. Harrison, and A. Markou Serotonergic manipulations both potentiate and reduce brain stimulation reward in rats: involvement of serotonin-1A receptors J. Pharmacol. Exp. Ther. 297 2001 316 325
30. A.A. Harrison, L.H. Parsons, G.F. Koob, and A. Markou RU 24969, a 5-HT1A/1B agonist, elevates brain stimulation reward thresholds: an effect reversed by GR 127935, a 5-HT1B/1D antagonist J. Pharmacol. Exp. Ther. 297 1999 316 325
31. D. Hervé, V.M. Pickel, H.J. Tong, and A. Beaudet Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons Brain Res. 435 1987 71 83
32. 2 agonist Ro 60-0175 and the indirect 5-HT agonist dexfenfluramine Br. J. Pharmacol. 133 2001 459 466
33. B.L. Jacobs, and C.A. Fornal Activity of serotonergic neurons in behaving animals Neuropsychopharmacology 21 1999 9S 15S (Suppl)
34. M. Jouvet Sleep and serotonin: an unfinished story Neuropsychopharmacology 21 1999 24S 27S (Suppl)
35. A. Kankaanpaa, E. Meririnne, and T. Seppala 5-HT3 receptor antagonist MDL 72222 attenuates cocaine- and mazindol-, but not methylphenidate-induced neurochemical and behavioral effects in the rat Psychopharmacology 159 2002 341 350
36. 2C/2B receptor antagonist Br. J. Pharmacol. 111 1994 797 802
37. 2C receptor antagonist Neuropharmacology 36 1997 609 620
38. 2C receptor agonist, in three animal models of anxiety Eur. J. Pharmacol. 387 2000 197 204
39. 1C receptors Neurosci. Biobehav. Rev. 16 1992 95 105
40. G.F. Koob Drugs of abuse: anatomy, pharmacology and function of reward pathways Trends Pharmacol. Sci. 13 1992 177 184
41. I. Lucki, H.R. Ward, and A. Frazer Effect of 1-(m-cholorophenyl) piperazine and 1-(m-trifluoromethylyphenyl)piperazine on locomotor activity J. Pharmacol. Exp. Ther. 249 1989 155 164
42. 2C receptor antagonist SB 242084, in tests of anxiety Pharmacol. Biochem. Behav. 71 2002 615 625
43. J.M. Mathé, F.F. Nomikos, N.E. Hildebrand, P. Hertel, and T.H. Svensson Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens Eur. J. Pharmacol. 309 1996 1 11
44. 2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo Neuropharmacology 37 1998 953 955
45. 1A agonists and dopamine: the effects of 8-OH-DPAT and buspirone on brain-stimulation reward J. Neural. Transm. Gen. Sect. 83 1991 139 148
46. 2A antagonist Behav. Brain Res. 73 1996 163 167
47. H. Moukhles, O. Bosles, J.P. Bolam, A. Vallée, D. Umbriaco, M. Geffard, and G. Doucet Quantitative and morphometric data indicate precise cellular interactions between serotonin and postsysnaptic targets in rat substania nigra Neuroscience 76 1997 1159 1171
48. J.L. Neisewander, S.A. McDougall, S.L. Bowling, and M.T. Bardo Conditioned taste aversion and place preference with buspirone and gepirone Psychopharmacology 100 1990 485 490
49. J.L. Neisewander, L.E. O'Dell, and J.C. Redmond Localization of dopamine receptor subtypes occupied by intra-accumbens antagonists that reverse cocaine-induced locomotion Brain Res. 671 1995 201 212
50. M. Nisell, G.G. Nomikos, P. Hertel, G. Panagis, and T.H. Svensson Condition-independent sensitization of locomotor stimulation and mesocortical dopamine release following chronic nicotine treatment in the rat Synapse 22 1996 369 381
51. M. Papp, and P. Willner 8-OH-DPAT-induced place preference and place aversion: effects of PCPA and dopamine antagonists Psychopharmacology 103 1991 99 102
52. L.H. Parsons, F. Weiss, and G.F. Koob Serotonin1B receptor stimulation enhances cocaine reinforcement J. Neurosci. 18 1998 10078 10089
53. R. Peltier, and S. Schenk Effects of serotonergic manipulations on cocaine self-administration in rats Psychopharmacology 110 1993 390 394
54. 2C) receptors in the ventrotegmental area inhibits stress-induced but not basal dopamine release in the rat prefrontal cortex J. Neurochem. 82 2002 93 100
55. F.O. Risinger, and R.A. Oakes Mianserin enhancement of ethanol-induced conditioned place preference Behav. Pharmacol. 7 1996 294 298
56. A.J. Roberts, R.A. McArthur, E.E. Hull, C. Post, and G.F. Koob Effects of amperozide, 8-OH-DPAT, and FG 5974 on operant responding for ethanol Psychopharmacology 137 1998 25 32
57. 1C receptor antagonists Behav. Pharmacol. 4 1993 101 106
58. J. Serrats, G. Mengod, and R. Cortes Expression of serotonin 5-HT2C receptors in GABAergic cells of the anterior raphe nuclei J. Chem. Neuroanat. 29 2005 83 91
59. T.S. Shippenberg Conditioned reinforcing effects of 8-hydroxy-2-(di-N- propylamino) tetralin: involvement of 5-hydroxytryptamine 1A and D1 dopamine receptors Neurosci. Lett. 121 1991 136 138
60. D.M. Tomkins, N. Joharchi, M. Tampakeras, J.R. Martin, J. Wichmann, and G.A. Higgins An investigation of the role of 5-HT (2C) receptors in modifying ethanol self-administration behaviour Pharmacol. Biochem. Behav. 71 2002 735 744
61. T.M. Tzschentke Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues Prog. Neurobiol. 56 1998 613 672
62. Waddock, S.L., 1997. Behavioral and neurochemical effects of 5HT-related drugs in a model of mesolimbic dopamine hyperactivity. University of Alberta, Edmonton, Canada. Thesis.
63. R.A. Wise, and P.P. Rompre Brain dopamine and reward Annu. Rev. Psychol. 40 1989 191 225